Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jul 15, 2011

Premium

Caprotec Bioanalytics this week appointed Marc Voigt as managing director, chief financial officer, and chief operating officer.

Voigt comes to the company from Medical Enzymes where he was chief financial officer and chief business officer. Prior to that he was chief financial officer and chief business officer at Revotar Biopharmaceuticals.


Thermo Fisher Scientific said this week it has elected Lars Rebien Sorensen to its board of directors.

Sorensen is president and CEO of healthcare company Novo Nordisk. He is also a member of the supervisory board of Bertelsmann and a director of Dong Energy.


Robert McBurney this week was named CEO of the Accelerated Cure Project for Multiple Sclerosis.

Formerly the CEO of Cambridge Neuroscience, McBurney has held senior positions at firms including BG Medicine and TheraGenetics and is the co-founder of Differential Proteomics and Optimal Medicine.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.